A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries

Clinical trial NCT00500812 · COMPLETED

Trial details

NCT number: NCT00500812
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Spinal Cord Injury

Start date: 2005-02-01
Primary completion: 2008-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.